Publicaciones en colaboración con investigadores/as de Universidad de Buenos Aires (25)

2023

  1. Targeting FOXP3 Tumor-Intrinsic Effects Using Adenoviral Vectors in Experimental Breast Cancer

    Viruses, Vol. 15, Núm. 9

  2. mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy

    Cell Reports Medicine, Vol. 4, Núm. 3

2022

  1. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

    The Lancet Oncology, Vol. 23, Núm. 7, pp. e334-e347

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. SPARC inhibition accelerates NAFLD-associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism

    Liver International, Vol. 41, Núm. 7, pp. 1677-1693

2020

  1. Should breast reconstruction and breast oncoplastic procedures be performed during the coronavirus pandemic?

    ecancermedicalscience, Vol. 14

2019

  1. Analysis of the results of a palliative care quality program for the last days of life: Ten years of experience

    Medicina (Argentina), Vol. 79, Núm. 6, pp. 468-476

  2. Withdrawing noninvasive ventilation at end-of-life care: Is there a right time?

    Current Opinion in Supportive and Palliative Care, Vol. 13, Núm. 4, pp. 344-350

2017

  1. Medical futility and family obstinacy in intensive therapy. When to stop and when to keep going?

    Medicina (Argentina), Vol. 77, Núm. 6, pp. 491-496

  2. Therapeutic blockade of Foxp3 in experimental breast cancer models

    Breast Cancer Research and Treatment, Vol. 166, Núm. 2, pp. 393-405

2014

  1. Palliative care staff perspectives: The challenges of end-of-life care on their professional practices and everyday lives

    Journal of Hospice and Palliative Nursing, Vol. 16, Núm. 3, pp. 165-172

2012

  1. Novel AKT1-GLI3-VMP1 pathway mediates KRAS oncogene-induced autophagy in cancer cells

    Journal of Biological Chemistry, Vol. 287, Núm. 30, pp. 25325-25334

2009

  1. Induction of hepatic aminolevulinate acid synthetase activity by isoflurane in a genetic model for erythropoietic protoporphyria

    Cellular and Molecular Biology, Vol. 55, Núm. 1, pp. 38-44

  2. The Influence of Baseline Parameters on Changes in International Prostate Symptom Score with Dutasteride, Tamsulosin, and Combination Therapy among Men with Symptomatic Benign Prostatic Hyperplasia and an Enlarged Prostate: 2-Year Data from the CombAT Study

    European Urology, Vol. 55, Núm. 2, pp. 461-471

2008

  1. Management of dyspnea in advanced motor neuron diseases

    Current Opinion in Supportive and Palliative Care, Vol. 2, Núm. 3, pp. 173-179

2007

  1. A new strategy to inhibit the excision reaction catalysed by HIV-1 reverse transcriptase: Compounds that compete with the template-primer

    Biochemical Journal, Vol. 405, Núm. 1, pp. 165-171

2005

  1. Effects of repeated administration with CP-55,940, a cannabinoid CB 1 receptor agonist on the metabolism of the hepatic heme

    International Journal of Biochemistry and Cell Biology, Vol. 37, Núm. 8, pp. 1620-1625

2004

  1. Volatile anaesthetics induce biochemical alterations in the heme pathway in a B-lymphocyte cell line established from hepatoerythropoietic porphyria patients (LBHEP) and in mice inoculated with LBHEP cells

    International Journal of Biochemistry and Cell Biology, Vol. 36, Núm. 2, pp. 216-222

2002

  1. Inhibitory Effect against Polymerase and Ribonuclease Activities of HIV-reverse Transcriptase of the Aqueous Leaf Extract of Terminalia triflora

    Phytotherapy Research, Vol. 16, Núm. 8, pp. 778-780

1999

  1. Argentine plant extracts active against polymerase and ribonuclease H activities of HIV-1 reverse transcriptase

    Phytotherapy Research, Vol. 13, Núm. 3, pp. 206-209